Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives (4th revised edition, 2008) – Suspension of Chapter 5 ’Human Albumin‘

Publisher： Karger

E-ISSN： 1660-3818|36|6|399-407

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.36, Iss.6, 2009-12, pp. : 399-407

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives (4th revised edition, 2008) – Suspension of Chapter 5 ‘Human Albumin’

By  

Transfusion Medicine and Hemotherapy, Vol. 38, Iss. 1, 2011-01 ,pp. : 71-71

Karger

Access to resources Recommend Favorite

Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives: Chapter 5 Human Albumin - Revised

By  

Transfusion Medicine and Hemotherapy, Vol. 43, Iss. 3, 2016-05 ,pp. : 223-232

Karger

Access to resources Recommend Favorite

Concerning Chapter 5 – Human Albumin; in Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives, 4th ed. Transfus Med Hemother 2009;36(6):399–407

By  

Transfusion Medicine and Hemotherapy, Vol. 37, Iss. 2, 2010-03 ,pp. : 98-99

Karger

Access to resources Recommend Favorite

Dried plasma/blood spots for monitoring antiretroviral treatment efficacy and pharmacokinetics: a cross‐sectional study in rural Burundi

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 5, 2015-05 ,pp. : 801-808

John Wiley & Sons Inc

Access to resources Recommend Favorite

Summary of the 5th Edition of the Renal Association Clinical Practice Guidelines (2009–2012)

By  

Nephron Clin Pract, Vol. 118, Iss. 1, 2011-05 ,pp. : c27-c70

Karger

Access to resources Recommend Favorite